Algo version: 0.98b
InnoCare Pharma Ltd is listed at the HKSE Exchange
InnoCare Pharma Ltd [9969.HK]
HKSE Sector: Biotechnology Industry:Biotechnology

Is InnoCare Pharma Ltd stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for InnoCare Pharma Ltd 10 years ago, but if you had invested on Monday 23rd of March 2020 when the price was HKD9.81, you would have made a loss of HKD-4.64 per share or -47.30%

Yes, the average daily trading liquidity for InnoCare Pharma Ltd is HKD3.51 million. You should therefore be able to get in and out of your positions relatively fast.

InnoCare Pharma Ltd has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for InnoCare Pharma Ltd to be medium [0.7 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.